OTC · EVRRF
Molecule Holdings Inc.
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
CNQ · HMPS.CN · CAD
Stock price, earnings
Quote as of Jul 23, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Hempsana Holdings Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hempsana Holdings Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hempsana Holdings Ltd. is an enterprise focused on cannabis extraction and purification, producing and distributing a wide array of cannabis derivatives for both the Canadian and international markets. The company's offerings include wholesale cannabis derivatives such as distillates, isolates, and crude CBD oil, alongside consumer-ready products like cannabis extracts, infused beverages, edibles, vape pens, tinctures, and topical applications. Hempsana further provides an extensive suite of services, including wholesale distribution, toll processing, and white-label contract manufacturing. Additionally, it offers specialized "as-a-service" solutions to other cannabis businesses, covering extraction, post-processing, and formulation support. Established in 2018, Hempsana Holdings Ltd. maintains its corporate headquarters in Toronto, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:58 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01CA$0.00 (0.0%)
Agra Ventures Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.33% below the high.
CA$0.01CA$0.00 (0.0%)
Camarico Investment Group Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01CA$0.00 (0.0%)
Medcolcanna Organics Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01CA$0.00 (0.0%)
Yooma Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Biome Grow Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Aequus Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.25% below the high.
$0.00$0.00 (0.0%)
Lords & Company Worldwide Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
